Breaking News

Univercells Technologies Launches Scale-X Nitro Controller

Offers a cost-effective, low-footprint, and user-friendly solution for large-scale viral and advanced therapy manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

Univercells Technologies, a Donaldson Life Sciences company and global provider of bioprocessing solutions, has launched the scale-X nitro controller, the latest addition to its scale-X fixed-bed bioreactor portfolio. Designed to operate both the 200 and 600 m² scale-X nitro bioreactors, the new controller offers a cost-effective, low-footprint, and user-friendly solution for large-scale viral and advanced therapy manufacturing, delivering high productivity and enabling rapid scalability from...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters